Immunome (IMNM) Soars 43%: What Details You Should Know?

The pretty uneven stock volatility can be seen on the chart for the last month. For example, the stock have increased starting from $16.50 on June 21 till $18.45 on June 28 which is also the highest one during the last 30 days. Afterwards, the stock started to slowly fall until it reached $15.76 on July 7. However, today it is soaring crazily in the premarket.

On July 20, Immunome made an announcement that the three of its antibody cocktail (IMM-BCP-01) show the great neutralizing activity in opposition to the SARS-CoV-2 Delta variant in the pre-clinical testing of the pseudovirus. Additionally, the IMM-BCP-01 displayed the in-vitro activity through the non-neutralizing mechanisms which are awaited by the company to help to get rid of the virus.

The company was rewarded with the technology award in the amount of $17.6 million from the U.S Department of Defense’s Joint Program Executive Office in partnership with the defense Health Agency in order to assistance the COVID program of the company.

Helen Larsen

After a long week of holidays in 2020, Helen realized she can do better in reporting Finance and Business news for Own Snap. Right now she is our weekend reporter and author. Sometimes she is busy with her projects that are related to her Master's Degree in Finance.

Want Hot Stocks?    Yes. I Love Them No thanks